HEMOTECH BELUX
ActiveSummary
HEMOTECH BELUX has been active since 2001 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €859,416 and a net result of €23,980. Equity is growing by about 27% per year across the filed financial years. Its solvency ranks better than 24% of 9,797 sector peers (NACE 46, financial year 2025). The computed 12-month bankruptcy probability is 0.9% (low).
Articles of association
- Other provisionsOther rules from the articles that fall under none of the themes above.
- 1 more provision in the deed, see the deed of 09-01-2023
Read from the deeds: 1 provision, deed of 09-01-2023